DBJ Capital
DBJ Capital is the corporate venture capital arm of the Development Bank of Japan, founded in 2010 through the merger of two DBJ Group venture firms. As a subsidiary of the Development Bank of Japan, DBJ Capital mobilizes the bank's full network to support investments in frontier technologies and new business models aimed at global growth, spanning industries and scales. It provides investment solutions ranging from growth-focused equity to financing schemes and assists venture startups through a value enhancement team that helps commercialize intellectual property and university- or research-developed technologies. The firm focuses on technology-driven and knowledge-intensive companies, including frontier tech, information technology services, biotechnology and healthcare, and other industrial sectors, with the aim of contributing to Japan's economic revival by helping investee firms grow and create new industries. Based in Tokyo, DBJ Capital operates as a corporate venture capital investor under the Development Bank of Japan.
Past deals in Japan
ShareDine
Series B in 2024
Founded in 2017, ShareDine operates an online platform offering personalized nutritional guidance and cooking experiences. It provides subscription services for traveling chefs specializing in various lifestyles and health conditions, such as pregnancy, diabetes, and muscle training. The company offers corporate wellness services like meal seminars and on-site chef dispatching.
REJECT
Series B in 2024
REJECT is an esports and entertainment organization based in Minato, Japan, founded in 2018. The company specializes in the management and operation of professional esports teams, focusing on fostering communication and creativity within the esports community. REJECT's platform aims to bridge gaps across various demographics, including language, generation, gender, and disability, contributing to the growth of the domestic esports market. By providing comprehensive team management and organizing campaigns, events, and exhibitions, REJECT plays a significant role in elevating esports players to national prominence.
KAKEAI
Series B in 2024
KAKEAI develops and operates an AI cloud platform for member management. The system aims to reduce misunderstandings about the characteristics and status of members and to make management knowledge accessible across an organization, enabling leaders to grasp the actual conditions at sites. Its main focus is supporting middle management, providing tools that improve communication, productivity, collaboration, and engagement among employees. The platform is designed to help organizations enhance HR processes and employee experience, delivering clearer insight into workforce realities and contributing to a better working environment and higher job satisfaction. The company was founded in 2018 and is based in Tokyo, Japan.
nearMe
Series C in 2024
NearMe Inc. is a Tokyo-based company founded in 2017 that specializes in mobile application development for taxi ride-sharing services. The company's platform addresses social inefficiencies by facilitating real-time matching of individuals seeking to travel in the same direction, thereby enabling them to share taxi rides. NearMe's innovative approach aims to enhance the commuting experience, making it more comfortable and efficient for users. Through its technology-driven solution, the company seeks to contribute to a sustainable and enjoyable society by optimizing transportation options for its users.
Cellusion
Series C in 2023
Cellusion is a regenerative medicine company developing induced pluripotent stem cell-derived corneal endothelial cells for the treatment of bullous keratopathy. The company focuses on research, development, manufacturing, and commercial supply of corneal endothelial cell substitutes for transplantation to restore corneal function and vision. Originating from Keio University, Cellusion aims to enable scalable, cell-based therapies by cultivating corneal endothelial cells from iPS sources and delivering them for surgical transplantation. Based in Tokyo, Japan, the company emphasizes advancing regenerative ophthalmology through cell-based therapies that offer less invasive treatment options for patients with endothelial corneal disease.
Kyoto Fusioneering
Series C in 2023
Founded in Kyoto, Japan in 2019, Kyoto Fusioneering is a privately funded technology company focused on developing advanced technologies for commercial fusion reactors. Their work includes gyrotron systems, tritium fuel cycle technologies, and breeding blankets for tritium production and power generation. The company aims to accelerate the realization of fusion energy as a viable, carbon-free power source.
Wakaze
Series B in 2023
Wakaze Inc. is a Japanese company that specializes in the development and manufacturing of craft sake and related products. Founded in 2016 and headquartered in Tsuruoka, Japan, with an additional office in Tokyo, the company markets its sake under the brands ORBIA and FONIA. Wakaze focuses on producing high-quality, affordable sake that can be enjoyed with a variety of cuisines, utilizing unique brewing techniques such as oak barrel aging and the incorporation of botanical ingredients and tea leaves. The company also offers a concierge service for sake, enhancing customer engagement. Additionally, Wakaze provides an online platform for consumers to purchase its products, which include various alcoholic beverages and snacks.
Techtouch
Series B in 2023
Techtouch, Inc., founded in 2018 and based in Tokyo, Japan, specializes in developing an intuitive website user manual called TechTouch. The company's software enhances system education for employees, supports burden reduction, and promotes system utilization by overlaying explanation guidance on existing web systems. This is achieved through a plug-in introduced on the web browser side and JavaScript on the server-side. Techtouch's platform minimizes operational stress by displaying real-time navigation directly on the screen of running web systems, enabling businesses to handle complex operations accurately and efficiently.
ShareDine
Series A in 2022
Founded in 2017, ShareDine operates an online platform offering personalized nutritional guidance and cooking experiences. It provides subscription services for traveling chefs specializing in various lifestyles and health conditions, such as pregnancy, diabetes, and muscle training. The company offers corporate wellness services like meal seminars and on-site chef dispatching.
Spacely
Venture Round in 2022
Founded in Tokyo, Japan in 2013, Spacely develops cloud-based software for creating and editing virtual reality (VR) content using 360-degree camera photos. Its intuitive platform caters to various industries such as real estate, tourism, and retail.
Kyoto Fusioneering
Series B in 2022
Founded in Kyoto, Japan in 2019, Kyoto Fusioneering is a privately funded technology company focused on developing advanced technologies for commercial fusion reactors. Their work includes gyrotron systems, tritium fuel cycle technologies, and breeding blankets for tritium production and power generation. The company aims to accelerate the realization of fusion energy as a viable, carbon-free power source.
Cellusion
Venture Round in 2022
Cellusion is a regenerative medicine company developing induced pluripotent stem cell-derived corneal endothelial cells for the treatment of bullous keratopathy. The company focuses on research, development, manufacturing, and commercial supply of corneal endothelial cell substitutes for transplantation to restore corneal function and vision. Originating from Keio University, Cellusion aims to enable scalable, cell-based therapies by cultivating corneal endothelial cells from iPS sources and delivering them for surgical transplantation. Based in Tokyo, Japan, the company emphasizes advancing regenerative ophthalmology through cell-based therapies that offer less invasive treatment options for patients with endothelial corneal disease.
Sprocket
Series C in 2021
Sprocket Inc. is a Tokyo-based company founded in 2014 that specializes in customer development applications. It offers a web-based platform designed to enhance customer service and optimize conversion rates through user behavior analysis. Sprocket's tool allows businesses to implement improvement cycles based on customer service scenarios, focusing on hypotheses and verification through testing. By analyzing key performance indicators and behavioral data, Sprocket enables companies to enhance the customer experience tailored to various industries, fostering long-term connections with end users. The platform is compatible with both Android and iOS, making it accessible for a wide range of users.
Kyulux
Series B in 2021
Kyulux is a material developer that researches and sells organic electroluminescence materials for OLED displays and lighting. The company specializes in thermally activated delayed fluorescence (TADF) emitters and Hyperfluorescence technology that combines TADF with fluorescent emitters to achieve high efficiency. Kyulux develops and supplies OLED materials and related solutions to manufacturers in the display and lighting industries, enabling cost-effective, durable, and efficient OLED devices without rare metals. Founded in 2015 and headquartered in Fukuoka, Japan, Kyulux owns or controls a substantial portfolio of TADF intellectual property developed with Kyushu University and industry partners, supporting the commercial adoption of next-generation OLEDs.
nearMe
Series A in 2020
NearMe Inc. is a Tokyo-based company founded in 2017 that specializes in mobile application development for taxi ride-sharing services. The company's platform addresses social inefficiencies by facilitating real-time matching of individuals seeking to travel in the same direction, thereby enabling them to share taxi rides. NearMe's innovative approach aims to enhance the commuting experience, making it more comfortable and efficient for users. Through its technology-driven solution, the company seeks to contribute to a sustainable and enjoyable society by optimizing transportation options for its users.
Aiforce Solutions
Venture Round in 2020
Aiforce Solutions Inc. specializes in artificial intelligence-based democratization solutions, offering a range of services designed to improve business operations through AI. Founded in 2018 and headquartered in Tokyo, Japan, with operations in Ho Chi Minh City, Vietnam, the company provides tools and services that enable non-experts to build and implement AI models with ease. Their flagship products include AMATERAS RAY, which assists businesses like ice cream chains and automobile manufacturers in demand forecasting, and AMATERAS EDU, an AI education service tailored for business applications. Additionally, Aiforce Solutions offers AI Development Due Diligence and AI Implementation Consulting, which help clients reform their businesses and develop prototypes at competitive costs. The company's focus is on facilitating the use of AI across various industries, enhancing accuracy, work efficiency, and cost-effectiveness for its clients.
Alivas
Series A in 2020
Alivas is a medical device company based in Tokyo, Japan, that develops a therapeutic device to treat refractory constipation. Founded in 2017, the company aims to provide a treatment option for patients with intractable chronic constipation. It is described as a joint venture between Stanford University and the University of Tokyo, in collaboration with the Japan Biodesign program for innovative medical device creation.
Techtouch
Series A in 2020
Techtouch, Inc., founded in 2018 and based in Tokyo, Japan, specializes in developing an intuitive website user manual called TechTouch. The company's software enhances system education for employees, supports burden reduction, and promotes system utilization by overlaying explanation guidance on existing web systems. This is achieved through a plug-in introduced on the web browser side and JavaScript on the server-side. Techtouch's platform minimizes operational stress by displaying real-time navigation directly on the screen of running web systems, enabling businesses to handle complex operations accurately and efficiently.
Photoruction
Venture Round in 2020
Founded in Tokyo in 2016, Photoruction specializes in developing cloud-based solutions for the construction industry. Its flagship product is a platform that streamlines construction photography and supports civil engineering production processes. The company also offers aoz cloud, an AI engine that reads information from drawings and photographs to enhance productivity.
TVISION INSIGHTS
Venture Round in 2020
TVISION INSIGHTS Co. Ltd., founded in 2015 and headquartered in Tokyo, Japan, specializes in media research focused on television. The company utilizes advanced human body recognition technology to measure and analyze the "viewing quality" of TV commercials and programs. This innovative approach allows TVISION INSIGHTS to capture unique data on TV viewing behavior in living rooms, creating a comprehensive dataset that is uncommon in the industry. With an emphasis on global expansion, the company has established additional offices in Boston and New York, and continues to pursue growth opportunities across various markets. By addressing the evolving challenges of the television landscape, TVISION INSIGHTS aims to unlock the full potential of TV as a medium.
Ginco
Series A in 2020
Ginco Inc. is a Tokyo-based company founded in 2017 that specializes in blockchain technology and cryptocurrency services. It develops and operates a mobile client-side cryptocurrency wallet known as Ginco, which supports multiple digital assets including Bitcoin, Ethereum, and others. The company's offerings extend beyond wallet applications to include crypto mining, enterprise wallet solutions, and node management services. Ginco aims to transform the relationship between individuals and their assets by leveraging blockchain technology, focusing on decentralized applications and on-chain functionalities. The company is also exploring opportunities for future development with decentralized exchanges, while maintaining a commitment to enhancing digital asset management and security through its multi-signature compatible wallets.
Kringle Pharma
Venture Round in 2020
Kringle Pharma is a Japanese biopharmaceutical company focused on the research and development of hepatocyte growth factor (HGF)–based protein medicines and NK4 therapies. The company aims to leverage HGF’s regenerative properties and NK4’s antiangiogenic activity to address organ repair and cancer indications. Its pipeline includes recombinant human HGF for acute renal failure, spinal cord injury, and CNS diseases, as well as recombinant NK4 and NK4 gene therapies for cancer. Founded in 2001, the company operates in the Japanese market.
Cellusion
Series A in 2020
Cellusion is a regenerative medicine company developing induced pluripotent stem cell-derived corneal endothelial cells for the treatment of bullous keratopathy. The company focuses on research, development, manufacturing, and commercial supply of corneal endothelial cell substitutes for transplantation to restore corneal function and vision. Originating from Keio University, Cellusion aims to enable scalable, cell-based therapies by cultivating corneal endothelial cells from iPS sources and delivering them for surgical transplantation. Based in Tokyo, Japan, the company emphasizes advancing regenerative ophthalmology through cell-based therapies that offer less invasive treatment options for patients with endothelial corneal disease.
nearMe
Series A in 2019
NearMe Inc. is a Tokyo-based company founded in 2017 that specializes in mobile application development for taxi ride-sharing services. The company's platform addresses social inefficiencies by facilitating real-time matching of individuals seeking to travel in the same direction, thereby enabling them to share taxi rides. NearMe's innovative approach aims to enhance the commuting experience, making it more comfortable and efficient for users. Through its technology-driven solution, the company seeks to contribute to a sustainable and enjoyable society by optimizing transportation options for its users.
RT Corporation
Series B in 2019
RT Corporation is a Japanese company based in Chiyoda-ku, established in 2005, that focuses on the development and sale of robots and their components. The company offers a diverse range of products, including army-type robots and micro mouse robots, such as the CRANE-X7 and RIC90, as well as various service robots tailored to meet both domestic and international needs. In addition to manufacturing, RT Corporation provides services in robot development, hardware and software development, and contract manufacturing. With the growing demand for robotics fueled by advancements in artificial intelligence, RT Corporation aims to innovate and expand its offerings in the service robot sector.
Motion Lib
Venture Round in 2019
Motion Lib, Inc. is a Japanese company specializing in the development of haptic technology aimed at enhancing collaboration between humans and robots. Founded in 2016 and based in Kawasaki, the company was previously known as Undou Sekkei Kenkyuusho Limited before rebranding in April 2017. Motion Lib creates advanced chips that estimate and calculate the repulsive force of objects being touched by robots, using the load force applied to the motor. This innovative technology enables robots to engage more effectively in various tasks, thereby expanding their operational capabilities and contributing to increased productivity across different sectors.
GITAI
Series A in 2019
GITAI is a Tokyo-based space robotics company developing humanoid telepresence robots to enable labor in space. Founded in 2016, it designs and deploys robotic systems for tasks on space stations, lunar bases, satellites, and related infrastructure, with the aim of reducing human workload and operational costs. Its products include the G1 general-purpose robot for automating a broad range of internal and external activities on space platforms, the S1 for specialized tasks and on-orbit servicing, and the H1 robot manipulation system for ground-based teleoperation of in-space operations. Through agile development and vertical integration, GITAI seeks to advance safe, reliable robotic labor for exploration, construction, maintenance, and research in space.
Spacely
Series A in 2019
Founded in Tokyo, Japan in 2013, Spacely develops cloud-based software for creating and editing virtual reality (VR) content using 360-degree camera photos. Its intuitive platform caters to various industries such as real estate, tourism, and retail.
Kyulux
Series B in 2019
Kyulux is a material developer that researches and sells organic electroluminescence materials for OLED displays and lighting. The company specializes in thermally activated delayed fluorescence (TADF) emitters and Hyperfluorescence technology that combines TADF with fluorescent emitters to achieve high efficiency. Kyulux develops and supplies OLED materials and related solutions to manufacturers in the display and lighting industries, enabling cost-effective, durable, and efficient OLED devices without rare metals. Founded in 2015 and headquartered in Fukuoka, Japan, Kyulux owns or controls a substantial portfolio of TADF intellectual property developed with Kyushu University and industry partners, supporting the commercial adoption of next-generation OLEDs.
Trajectory
Venture Round in 2019
Trajectory, Ltd. is a Tokyo-based company established in 2018 that specializes in the research and development of control systems for unmanned aerial vehicles (UAVs). The company has created an AI Traffic Control system that facilitates fully autonomous navigation for drones. Its innovative technology allows for the automated generation of flight routes for multiple UAVs, enabling simultaneous deployment and operation. By providing clients with a safe and accessible environment for UAV usage, Trajectory aims to address various operational challenges associated with unmanned aircraft.
Meleap
Series B in 2018
Meleap is a Japanese company founded in 2014 that specializes in developing innovative gaming experiences. It offers an augmented reality (AR) sport called HADO, which combines physical activity with technology. Players wear head-mounted displays and armband sensors to compete in teams, using 'energy balls' or 'shields' to earn points.
Medical Care Service Company
Acquisition in 2018
Medical Care Service Company Inc. is a Japanese firm that specializes in providing comprehensive nursing care services, particularly for the elderly suffering from dementia. Established in 1999 and based in Saitama, the company operates over 210 group homes and seven paid nursing homes, offering a range of services that include assisted living, daily functional training, and in-home care support. Additionally, it provides day care services, nursing support for daily living activities, and sells or rents welfare equipment such as wheelchairs and walking aids. Medical Care Service Company Inc. focuses on enhancing the quality of life for its residents through personalized care and support, while also being involved in personnel recruitment and placement within the healthcare sector.
Alivexis
Series A in 2018
Alivexis is a private preclinical stage drug discovery company based in Tokyo, specializing in the rapid design and generation of small molecule clinical candidates targeting high-value disease conditions. The company leverages advanced computational drug discovery techniques and unique biological insights to expedite the development of new medicines. Its international team comprises experts in drug design and disease biology, drawing on extensive research and development experience from global pharmaceutical, biotechnology, and technology firms. By focusing on innovative approaches, Alivexis aims to enhance biotechnological research and improve the efficiency of delivering essential medicines to patients with unmet medical needs.
Curadim Pharma
Venture Round in 2018
Curadim Pharma, established in 2016 and headquartered in Tokyo, Japan, is a biotechnology company focused on discovering innovative drug candidates. The company specializes in identifying and developing novel pharmaceutical products to address diseases with significant unmet medical needs. Curadim Pharma's efforts are concentrated on advancing these drug candidates from the discovery phase through early clinical development, aiming to create value by bringing them to the non-clinical stage.
TL Genomics
Venture Round in 2018
TL Genomics Co., Ltd., founded in 2015 and based in Tokyo, Japan, specializes in DNA testing services with a focus on prenatal diagnosis. The company has developed an innovative technology that isolates fetal nucleated red blood cells from maternal blood, allowing for the examination of the fetal genome. This non-invasive approach enables early and definitive diagnosis of fetal chromosomal disorders during pregnancy. Additionally, TL Genomics provides laminated microfluidic devices that facilitate massive cell fractionation, enhancing the capabilities of healthcare providers in ensuring safe pregnancies for their patients.
Spacely
Seed Round in 2018
Founded in Tokyo, Japan in 2013, Spacely develops cloud-based software for creating and editing virtual reality (VR) content using 360-degree camera photos. Its intuitive platform caters to various industries such as real estate, tourism, and retail.
Megakaryon
Series C in 2017
Founded in 2011, Megakaryon is a Japanese biotechnology company specializing in the development of blood products derived from human induced pluripotent stem cells (iPSCs). Its primary focus is on creating platelets and red blood cells independent of traditional blood donations.
Meleap
Series A in 2017
Meleap is a Japanese company founded in 2014 that specializes in developing innovative gaming experiences. It offers an augmented reality (AR) sport called HADO, which combines physical activity with technology. Players wear head-mounted displays and armband sensors to compete in teams, using 'energy balls' or 'shields' to earn points.
Timers
Venture Round in 2017
Timers Inc. is a Tokyo-based company that develops a variety of mobile applications catering to different social needs. Their flagship product, 'Pairy', is a social networking application specifically designed for couples, fostering connection and interaction. Additionally, Timers offers applications aimed at singles for matchmaking purposes. The company also provides a family-oriented application that enables users to create monthly calendars and photo albums for child-rearing families, allowing them to share memories and strengthen family bonds. Through these diverse offerings, Timers Inc. seeks to enhance social engagement and familial relationships.
Truss
Venture Round in 2017
Truss is a Tokyo-based company that offers an online platform for comparing building materials, catering specifically to the construction industry. The platform serves as a comprehensive database, providing detailed information on various building material products from multiple manufacturers. Users can search and compare materials based on specific parameters, such as performance metrics and necessary conditions, streamlining the selection process for construction projects. By facilitating access to extensive material data, Truss enhances decision-making for professionals in the construction sector.
RT Corporation
Series A in 2017
RT Corporation is a Japanese company based in Chiyoda-ku, established in 2005, that focuses on the development and sale of robots and their components. The company offers a diverse range of products, including army-type robots and micro mouse robots, such as the CRANE-X7 and RIC90, as well as various service robots tailored to meet both domestic and international needs. In addition to manufacturing, RT Corporation provides services in robot development, hardware and software development, and contract manufacturing. With the growing demand for robotics fueled by advancements in artificial intelligence, RT Corporation aims to innovate and expand its offerings in the service robot sector.
Smart Trade
Seed Round in 2017
Smart Trade Inc. is a Tokyo-based information technology company that operates a personalized, do-it-yourself online investment platform. Founded in 2016, the company specializes in providing an advanced quantitative investment analysis environment, leveraging a deep learning engine to assist investors in making informed trading decisions. The platform features an artificial intelligence engine, real-time trading capabilities, and a backtesting engine, allowing users to develop and test their trading strategies. It also serves as an online marketplace where software developers can upload and sell their investment strategies, and users can either buy or rent these strategies from others within the community.
ReasonWhy
Venture Round in 2017
ReasonWhy Inc., founded on July 7, 2011, is a Japan-based company that specializes in healthcare IT services. The company offers a suite of innovative solutions designed to enhance communication and information access within the medical field. Its key services include Whytlink, a social network tailored for medical professionals; Findme, an online platform that connects patients with doctors for second opinions; WhytPlot, a big-data analysis tool aimed at pharmaceutical manufacturers; and yourHospital, a search engine that helps users find specialist hospitals. Through these services, ReasonWhy aims to improve healthcare delivery and facilitate better patient outcomes.
Coconala
Venture Round in 2017
Coconala Inc. is a Tokyo-based company that operates an online platform facilitating the buying and selling of knowledge, skills, and experiences between users. Founded in 2012, the platform enables individuals to offer various services, including fortune-telling, mental wellness support, illustration, design, and consultations related to hobbies and travel. Originally known as Wellself, the company rebranded to Coconala in June 2014, reflecting its focus on connecting users who are eager to teach with those seeking to learn.
Magellan Systems Japan
Venture Round in 2017
Magellan Systems Japan, Inc. is a company dedicated to the research, development, and licensing of high-precision satellite positioning systems. Founded in 1987 and headquartered in Amagasaki, Japan, the company specializes in a range of technologies including semi-software and software global positioning systems (GPS), digital signal processing systems, and multi-frequency global navigation satellite systems (GNSS). It also develops advanced GNSS real-time kinematic systems and inertial measurement systems, providing solutions for GPS timing and autonomous ephemeris prediction. In addition to its core development activities, Magellan Systems Japan imports and sells GNSS-related products, supporting the utilization of artificial satellite technology in various applications.
Kringle Pharma
Venture Round in 2016
Kringle Pharma is a Japanese biopharmaceutical company focused on the research and development of hepatocyte growth factor (HGF)–based protein medicines and NK4 therapies. The company aims to leverage HGF’s regenerative properties and NK4’s antiangiogenic activity to address organ repair and cancer indications. Its pipeline includes recombinant human HGF for acute renal failure, spinal cord injury, and CNS diseases, as well as recombinant NK4 and NK4 gene therapies for cancer. Founded in 2001, the company operates in the Japanese market.
Karydo Therapeutix
Seed Round in 2016
Karydo Therapeutix, Inc. is a biotechnology company focused on developing advanced technologies for the early detection and prevention of diseases. Founded in 2015 and based in Tokyo, Japan, the company utilizes its iOrgans technology platform, which includes various sub-technologies such as Reverse-iOrgans, Forward-iOrgans, and Drug-iOrgans. These technologies leverage data science and artificial intelligence to create a digital twin of the human body, allowing for real-time monitoring of molecular, cellular, and organ relationships. By detecting early disease indicators and identifying potential drug side effects, Karydo Therapeutix aims to enhance the efficiency of drug development for pharmaceutical companies while providing insights for proactive healthcare management.
Kyulux
Series A in 2016
Kyulux is a material developer that researches and sells organic electroluminescence materials for OLED displays and lighting. The company specializes in thermally activated delayed fluorescence (TADF) emitters and Hyperfluorescence technology that combines TADF with fluorescent emitters to achieve high efficiency. Kyulux develops and supplies OLED materials and related solutions to manufacturers in the display and lighting industries, enabling cost-effective, durable, and efficient OLED devices without rare metals. Founded in 2015 and headquartered in Fukuoka, Japan, Kyulux owns or controls a substantial portfolio of TADF intellectual property developed with Kyushu University and industry partners, supporting the commercial adoption of next-generation OLEDs.
Normee
Venture Round in 2016
Normee Limited, established in Tokyo, Japan on February 1, 2005, specializes in developing palm recognition technology for user identification and smartphone unlocking. The company's core product is a vein authentication system that utilizes the built-in camera of smartphones or tablets to detect unique palm patterns, offering accurate biometric security solutions. Normee aims to facilitate hybrid biometric authentication tailored to different operating environments.
ClipLine
Seed Round in 2016
ClipLine provides a video-based service for businesses with multiple locations, facilitating management across diverse industries such as retail, nursing care, transportation, and factories. Launched in 2014, ClipLine serves approximately 15,000 stores and 420,000 users, promoting digital transformation and enhancing organizational execution.
On-chip Biotechnologies
Venture Round in 2015
Founded in Tokyo, Japan in 2005, On-chip Biotechnologies develops and manufactures innovative medical devices. Its flagship product is FISHMAN-R, a biosafety flow cytometer that enables flow cytometry on a microfluidics chip, detecting bacteria and cells with minimal sample quantity.
Research and Innovation
Venture Round in 2015
Research and Innovation Co., Ltd. is a Tokyo-based market research company established in 2011, specializing in providing marketing research and information services through the Internet. The company offers a range of services, including barcode research, promotional programs, brand image association surveys, and consumer investigations. Its platforms, under the CODE and Mycomment brands, facilitate insights into consumer behavior, promotional effectiveness, and market trends. Research and Innovation serves diverse sectors such as food, beauty, retail, finance, and entertainment, helping clients understand consumer preferences and improve their strategies. By utilizing data analysis, the company empowers businesses to anticipate market trends and enhance revenue growth.
A-Traction
Seed Round in 2015
A-Traction Inc. is a Japanese company based in Kashiwa, Chiba, specializing in the development of surgical robots designed for laparoscopic surgery. Founded in 2015, A-Traction aims to enhance surgical precision and safety through innovative medical devices. The company has introduced a concept called ANSUR, wherein the robotic system acts as a collaborative partner to the surgeon during procedures, facilitating smoother and more effective operations. By leveraging advanced technology and a unique approach to robotic assistance, A-Traction seeks to provide high-quality surgical solutions that improve outcomes for patients while ensuring a safer surgical environment.
SmileWorks
Venture Round in 2015
SmileWorks Inc., founded in 2003 and based in Hirata, Shimane, Japan, specializes in designing and developing cloud-based and web-based application services tailored for ministries and small to mid-size businesses (SMBs). The company's software solutions include a comprehensive ERP system that integrates various back-office operations such as sales management, purchasing management, project income and expenditure management, inventory management, financial accounting, payroll calculation, and expense settlement. Additionally, SmileWorks offers automatic payment reconciliation and cash flow management through API collaboration with banks, along with accounts receivable liquidation services to enhance clients' productivity.
Gengo
Series C in 2015
Gengo, Inc. is a translation service provider that operates a professional human translation platform, facilitating connections between individuals and businesses and a community of over 18,000 qualified translators from 114 countries. Founded in 2008 and headquartered in Tokyo, Japan, with an office in San Mateo, California, Gengo offers its services through a web platform and an open API, enabling clients to order translations for various content types, including product descriptions and social media posts, in multiple languages. The company serves a diverse clientele, including notable names such as JTB, TripAdvisor, BuzzFeed, and Rakuten. Gengo's platform is designed to provide higher quality translations compared to machine translation, while also ensuring quicker delivery times than traditional translation service providers. As of December 31, 2018, Gengo operates as a subsidiary of Lionbridge Technologies, Inc.
Gengo
Series C in 2015
Gengo, Inc. is a translation service provider that operates a professional human translation platform, facilitating connections between individuals and businesses and a community of over 18,000 qualified translators from 114 countries. Founded in 2008 and headquartered in Tokyo, Japan, with an office in San Mateo, California, Gengo offers its services through a web platform and an open API, enabling clients to order translations for various content types, including product descriptions and social media posts, in multiple languages. The company serves a diverse clientele, including notable names such as JTB, TripAdvisor, BuzzFeed, and Rakuten. Gengo's platform is designed to provide higher quality translations compared to machine translation, while also ensuring quicker delivery times than traditional translation service providers. As of December 31, 2018, Gengo operates as a subsidiary of Lionbridge Technologies, Inc.
Megakaryon
Series B in 2015
Founded in 2011, Megakaryon is a Japanese biotechnology company specializing in the development of blood products derived from human induced pluripotent stem cells (iPSCs). Its primary focus is on creating platelets and red blood cells independent of traditional blood donations.
Cyfuse Biomedical
Venture Round in 2015
Cyfuse Biomedical specializes in developing tissue fabrication systems and cell-based products for global research institutions. It offers a robotic 3D BioFabrication system, producing various tissue grafts for therapeutic use, drug development, and research purposes. Founded in 2010, the company is headquartered in Tokyo, Japan.
Lacras
Venture Round in 2014
Founded in Tokyo, Japan in 2005, Lacras is a HR technology company specializing in cloud-based HR services. It offers solutions to streamline HR processes, including personnel business process outsourcing and talent management functions.
Jtower
Venture Round in 2014
JTOWER Inc. is a telecommunications infrastructure company based in Tokyo, Japan, specializing in infrastructure sharing services. Founded in 2012, the company focuses on the design and construction of information communication infrastructure, as well as the development of communication-related solutions. JTOWER provides a range of services that include in-building infrastructure sharing, cloud-managed Wi-Fi, outdoor tower sharing, and local 5G services, catering primarily to landlords and mobile network operators. Additionally, it offers site locator systems to facilitate the deployment of mobile infrastructure. As a subsidiary of Nippon Telegraph and Telephone Corporation, JTOWER plays a vital role in enhancing telecommunications infrastructure across Japan.
Research and Innovation
Venture Round in 2014
Research and Innovation Co., Ltd. is a Tokyo-based market research company established in 2011, specializing in providing marketing research and information services through the Internet. The company offers a range of services, including barcode research, promotional programs, brand image association surveys, and consumer investigations. Its platforms, under the CODE and Mycomment brands, facilitate insights into consumer behavior, promotional effectiveness, and market trends. Research and Innovation serves diverse sectors such as food, beauty, retail, finance, and entertainment, helping clients understand consumer preferences and improve their strategies. By utilizing data analysis, the company empowers businesses to anticipate market trends and enhance revenue growth.
Looop
Seed Round in 2014
Looop Inc. is a renewable energy company based in Tokyo, Japan, specializing in the construction, development, and maintenance of solar power generation systems. Founded in 2011, Looop provides services that encompass the entire value chain, including the development, sales, and operation of photovoltaic power stations. By owning and managing the processes involved in solar energy production, the company aims to lower costs and promote sustainable living. Looop's offerings facilitate a seamless transition for customers looking to adopt renewable energy solutions, thereby contributing to the growth of the solar energy sector.
gumi
Series H in 2014
gumi Inc. is a Japan-based entertainment company that specializes in developing, operating, and distributing online games for mobile devices. Founded in 2007 by CEO Hironao Kunimitsu, gumi has expanded its presence internationally, with multiple subsidiaries across Asia, Europe, and North America. The company provides a diverse range of services, including native application development, browser-based gaming, and game localization for third-party content. In addition to its core gaming business, gumi is actively involved in the blockchain sector and explores emerging technologies within the XR space, encompassing virtual, augmented, and mixed reality. Headquartered in Tokyo, gumi aims to deliver engaging gaming experiences while maintaining a creative and passionate approach to content development.
GlyTech
Series A in 2014
GlyTech specializes in the production of human-type N-glycans and chemical glycosylation technologies. It offers custom synthesis services, contract manufacturing, and licenses its products for use in biopharmaceuticals and oligonucleotide therapeutics.
Streetmedia
Venture Round in 2013
Streetmedia, Inc. is a Tokyo-based company that specializes in media services for commercial areas in Japan. Established in 2008, the company develops a media service platform that provides current information on street media. Its offerings include shopping media and area casting, which allow clients to gather insights from local media businesses. This platform enables users to access valuable knowledge on business development topics from around the globe, facilitating informed decision-making in the commercial sector.
gumi
Series G in 2013
gumi Inc. is a Japan-based entertainment company that specializes in developing, operating, and distributing online games for mobile devices. Founded in 2007 by CEO Hironao Kunimitsu, gumi has expanded its presence internationally, with multiple subsidiaries across Asia, Europe, and North America. The company provides a diverse range of services, including native application development, browser-based gaming, and game localization for third-party content. In addition to its core gaming business, gumi is actively involved in the blockchain sector and explores emerging technologies within the XR space, encompassing virtual, augmented, and mixed reality. Headquartered in Tokyo, gumi aims to deliver engaging gaming experiences while maintaining a creative and passionate approach to content development.
CMerTV Japan
Venture Round in 2013
CMerTV, Inc. is a Tokyo-based company that specializes in the planning, design, and operation of video advertising portal sites. Established in 2010, the firm focuses on the production and editing of videos, as well as the distribution of video advertisements. CMerTV connects advertisers with various media outlets, including newspapers and magazines, enhancing the promotional reach of brands through its video advertising network. The company operates as a subsidiary of VOYAGE GROUP, Inc., and aims to serve the media industry effectively by providing in-banner and in-stream video advertising solutions.
Capable
Seed Round in 2013
Capable Co., Ltd., founded on July 13, 2012, is an engineering firm based in Kyoto, Japan, specializing in the manufacture of metal molds for semiconductor sealing. The company focuses on providing comprehensive molding solutions, including a revolutionary mold production system that enhances precision in mold chase technology. Capable's offerings include the fabrication, inspection, and assembly of mold parts, which are then sold alongside light-emitting diodes and electronic components. This approach enables clients to obtain customized mold chases at competitive prices, catering to a diverse range of customer needs in the semiconductor industry.
Siglead
Venture Round in 2013
Siglead specializes in research and development of error correction algorithms for Solid State Drives (SSDs). It designs, develops, and sells signal processing LSI and intellectual property. The company offers NAND flash memory analyzer systems, SSD controller LSI, and FPGA evaluation boards for high-speed signal processing.
PRISM Pharma
Series C in 2013
PRISM Pharma develops and provides biotechnology solutions for medical oncology. It researches on small molecule technologies that offers drug discovery services. PRISM Pharma is based in Yokohama, Japan.
Marketing Applications
Venture Round in 2012
Marketing Applications, Inc. is a leading provider of market research solutions, specializing in online panels across Asia and comprehensive research services worldwide. Founded in 2006 and headquartered in Tokyo, Japan, with an additional office in Singapore, the company delivers a robust platform that supports researchers through cloud-based survey systems, tabulation tools, and consumer panels. Its clientele encompasses a diverse range of sectors, including market research firms, media and advertising agencies, consumer goods manufacturers, consulting firms, and financial institutions. The company has established itself as a key player in the marketing research field, serving over 200 companies in Japan alone and facilitating advanced analysis and insights to help businesses effectively conduct surveys and interpret data.
Octoba
Venture Round in 2012
Octoba Inc. is a company based in Tokyo, Japan, founded in June 2004. It specializes in the planning, development, and operation of smartphone applications and operates a media platform focused on smartphone content. Known for its application information media, Oktober, Octoba has introduced tens of thousands of apps since its inception in 2009. The company provides a review site that offers crucial information to users, particularly those on Android, facilitating their search for and usage of various applications.
gumi
Series F in 2011
gumi Inc. is a Japan-based entertainment company that specializes in developing, operating, and distributing online games for mobile devices. Founded in 2007 by CEO Hironao Kunimitsu, gumi has expanded its presence internationally, with multiple subsidiaries across Asia, Europe, and North America. The company provides a diverse range of services, including native application development, browser-based gaming, and game localization for third-party content. In addition to its core gaming business, gumi is actively involved in the blockchain sector and explores emerging technologies within the XR space, encompassing virtual, augmented, and mixed reality. Headquartered in Tokyo, gumi aims to deliver engaging gaming experiences while maintaining a creative and passionate approach to content development.
tella
Venture Round in 2011
Founded in Tokyo, Japan in 2004, tella specializes in the research and development of regenerative and cell medicines, with a focus on dendritic cell vaccine therapy for cancer treatment. The company offers operational support to affiliated medical institutions, including consultation services for establishing cell processing centers, training technicians, and supporting therapies assessment.
Berg Earth
Venture Round in 2010
Berg Earth specializes in the production and sale of vegetable seedlings, offering a variety of types such as earth-in-lock, early rise early, pot seedlings, cell seedling, virus guard seedlings, high-legged seedlings, twin seedlings, nude makeup seedlings, and ground straight seedlings. Additionally, they engage in the purchase and sale of agricultural products and materials.
Full Speed
Post in 2010
Full Speed Inc. is a Tokyo-based company specializing in internet marketing support services in Japan. Founded in 2001, it offers a comprehensive range of services, including search engine optimization (SEO), listing and affiliate advertising, display advertising, and social media advertising. The company operates through several segments: the Internet Advertising Agency segment focuses on listing advertising and search engine marketing, while the Ad Network segment provides integrated advertising network services. Additionally, Full Speed's Information Media segment is involved in the planning and creation of information sites and e-commerce platforms. The Creative segment offers website and banner creation services. The company also provides consulting services in SEO, social media operations, web architecture, and advertisement effect measurement, along with specialized services in healthcare marketing. Full Speed Inc. is a subsidiary of FreeBit Co., Ltd.
KnowledgeSuite
Venture Round in 2010
KnowledgeSuite is a Tokyo-based company specializing in the development of SaaS business applications in Japan. Established in 2006, KnowledgeSuite is a subsidiary of KDDI Corporation.
MonotaRO
Post in 2010
MonotaRO Co., Ltd. is a Japanese e-commerce company that specializes in the sale of maintenance, repair, and operations (MRO) products. Established in 2000 and headquartered in Amagasaki, Japan, the company serves a wide range of industries, including manufacturing, construction, and automotive, through its online platform. MonotaRO operates not only in Japan but also in Korea, China, Indonesia, and other international markets. Originally known as Sumisho Grainger Co., Ltd., the company rebranded in February 2006 to better reflect its focus on industrial supply products.
Aisei Pharmacy
Seed Round in 2010
Aisei Pharmacy is engaged in the retail sales of prescription drugs, proprietary drugs, and non-prescription medicines, operating a network of over 350 dispensing pharmacies across Japan. Founded in September 1984 and headquartered in Marunouchi, Chiyoda-ku, Tokyo, the company accepts prescriptions from various medical institutions. In addition to its pharmacy operations, Aisei Pharmacy runs dispensary clinics that provide nursing care and medicines to patients, as well as preventive health check-ups aimed at promoting overall wellness. This dual approach enables the company to serve both ill and healthy individuals, supporting their health maintenance and medical needs.
All Ads
Venture Round in 2008
All Ads is a Tokyo-based company that specializes in digital marketing services aimed at enhancing the cost-effectiveness of advertising for business professionals. The company focuses on lifetime value (LTV) marketing, integrating data, technology, and consulting to optimize advertising strategies. In addition to LTV marketing, All Ads provides in-house media management and licensing services, which encompass affiliate advertising consulting, operational advertising consulting, and roundtable discussions. The company's mission is to support the growth of advertisers by improving their advertising performance and overall business outcomes.
Emergency Assistance Japan
Venture Round in 2007
Emergency Assistance Japan Co., Ltd. is a Tokyo-based company that specializes in providing comprehensive medical and lifestyle assistance services both in Japan and internationally. Founded in 2003, the company offers a diverse range of services, including medical assistance, security assistance programs, travel assistance, and lifestyle support. Additionally, it provides risk management services specifically tailored for overseas students, as well as emergency response services and support for foreign nationals. Through its various programs, Emergency Assistance Japan aims to ensure safety and well-being for individuals navigating challenges in unfamiliar environments.
Cyberdyne
Seed Round in 2007
Cyberdyne Inc. is a Japanese company founded by Dr. Yoshiyuki Sankai from the University of Tsukuba, focusing on the research and development of advanced medical welfare equipment and systems. The company aims to enhance human capabilities through its innovative Robot Suit HAL®, which is designed for various applications including rehabilitation support, assistance for the elderly and disabled, disaster rescue, entertainment, and heavy labor tasks. Cyberdyne's product offerings include the Hybrid Assistive Limb (HAL) for lower limbs and single joints, along with lumbar support, a Table Interface, and cleaning robots. Additionally, the company provides services such as HAL therapy in the medical sector and non-medical services like HAL fit and Robo care, all contributing to improved quality of life and support in various fields.
SymBio Pharmaceuticals
Seed Round in 2005
SymBio Pharmaceuticals is a biopharmaceutical company focused on the research, development, manufacturing, and marketing of pharmaceutical drugs. Its primary areas of focus are oncology and hematology. SymBio's portfolio includes Treakisym SyB L-0501 for treating various blood cancers, SyB L-1701 and SyB L-1702 for rapid infusion, Rigosertib SyB-C-0501 for solid tumors and systemic lupus erythematosus, SyB L-1101 for higher-risk myelodysplastic syndromes, SyB C-1101 for combination therapy with azacitidine, and SyB V-1901 for antiviral treatment. SymBio operates primarily in Asia.
Gene Techno Science
Seed Round in 2004
Founded in 2001, Gene Techno Science is a Japanese biopharmaceutical company dedicated to researching and developing innovative drugs. Its portfolio includes treatments for immunological, cardiovascular, ophthalmic, infectious, renal diseases, and oncology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.